Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2019

Sep 19, 2019

32106_dirs_2019-09-18_1584ee9c-17bd-4517-864e-67834c01ef3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2019-09-17

Reporting Person: Schick Joseph C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-17 Common Stock M 1713 $1.90 Acquired 8588 Direct
2019-09-17 Common Stock S 1713 $21 Disposed 6875 Direct
2019-09-18 Common Stock M 3287 $1.90 Acquired 10162 Direct
2019-09-18 Common Stock S 3287 $21 Disposed 6875 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-17 Employee Stock Option $1.90 M 1713 Disposed 2025-03-15 Common Stock (1713) Direct
2019-09-18 Employee Stock Option $1.90 M 3287 Disposed 2025-03-15 Common Stock (3287) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.